Press Releases

LEUKOCARE receives growth capital funding by LifeCare Partners and strengthens its board with industry experts

LEUKOCARE participates in European consortium to validate blood-based biomarkers for cancer

New book release covering Biofunctional Surface Engineering of medical devices

LEUKOCARE is pleased to announce the launch of its new website in March 2014

LEUKOCARE licenses its stabilizing and protecting technologies for veterinarian vaccine

Scil Proteins and LEUKOCARE develop a stabilized recombinant human thrombin manufactured in bacteria

Innovative Influenza A vaccine formulation increases stability and provides new options for production and storage

Xenios and LEUKOCARE announce strategic partnership in the field of anti-inflammatory coatings for next generation extracorporeal support systems

LEUKOCARE announces EUR 3.4 M capital increase

LEUKOCARE in collaboration with Technical University Munich (TUM) develops a novel HBV vaccine and receives grant by German government